Fungal coinfection/superinfection in COVID-19 patients in a tertiary hospital in Mexico
Abstract
Introduction: Data on the prevalence of fungal coinfections/superinfections in patients with COVID-19 are limited. Objective: Describe the prevalence of fungal coinfections/superinfections in patients with COVID-19, as well as risk factors and demographic, clinical, and microbiological characteristics in a tertiary hospital in Mexico. Material and methods: Patients with a confirmed COVID-19 diagnosis and a confirmed fungal infection hospitalized in the ICU from March 2020–December 2021 were included. Data on age, sex, comorbidities, hospital length of stay (days), laboratory (ferritin) and microbiological results, treatment for COVID-19, antifungal therapy, and outcome were obtained from the clinical record. Results: 11/740 patients met the inclusion criteria. The coinfection and superinfection rates were 0.3% and 1.2%, respectively. The most affected population was male adults. The coinfections/superinfections diagnosed were candiduria and candidemia, caused by Candida albicans, C. tropicalis, C. glabrata, C. lusitaniae, and Kluyveromyces marxianus (C. kefyr). In addition, tracheobronchitis due to Aspergillus fumigatus was found. The most used antifungals were fluconazole and caspofungin. The lethality in patients with fungal coinfections and superinfections was 50% and 22%, respectively. The length of hospital stay was 11-65 days. Eight patients required mechanical ventilation and six received corticosteroids. The main comorbidity was diabetes mellitus (81.8%). Conclusions: The rate of fungal coinfections/superinfections in COVID-19 patients was low, but the lethality found urges for routine fungal screening in patients with severe COVID-19 to timely detect fungal infections that may further compromise the patient's life.
Downloads
Some similar items:
- Jorge Alberto Cortés, José Franklin Ruiz, Lizeth Natalia Melgarejo-Moreno, Elkin V. Lemos, Candidemia in Colombia , Biomedica: Vol. 40 No. 1 (2020)
- Juan Manuel Senior, Clara Saldarriaga, Endocarditis due to infection by Paecilomyces variotii , Biomedica: Vol. 29 No. 2 (2009)
- Carolina Firacative, Germán Torres, María Claudia Rodríguez, Patricia Escandón, First environmental isolation of Cryptococcus gattii serotype B, from Cúcuta, Colombia , Biomedica: Vol. 31 No. 1 (2011)
- José Humberto Bravo, Andrés Mauricio Agudelo, Armando Cortés, Lorena Matta, Rhino-orbito-cerebral mucormycosis from dental origin: Case report , Biomedica: Vol. 38 No. 1 (2018)
- Julián Alfredo Fernández-Niño , Andrés Cubillos-Novella, Ietza Bojórquez , Michael Rodríguez , Recommendations for the response against COVID-19 in migratory contexts under a closed border: The case of Colombia , Biomedica: Vol. 40 No. Supl. 2 (2020): SARS-CoV-2 y COVID-19
- Claudia Milena Cuéllar-Segura, Lessons learned in public health from COVID-19: A look towards future epidemics and pandemics , Biomedica: Vol. 42 No. Sp. 2 (2022): Covid-19
- Jorge Alonso Rivera , Sheryll Corchuelo , Edgar Alberto Parra , Eugenio Aladino Meek, Marcela Mercado, Orlando Torres-Fernández, Inmunohistochemical detection of pandemic SARSCoV- 2 antigens in lung tissue , Biomedica: Vol. 42 No. Sp. 2 (2022): Covid-19
- Jorge Rivera , Sheryll Corchuelo, Julián Naizaque, Édgar Parra, Eugenio Aladino Meek, Diego Álvarez-Díaz, Marcela Mercado , Orlando Torres-Fernández, Histopathology of COVID-19: An illustration of the findings from fatal cases , Biomedica: Vol. 43 No. 1 (2023)
- María Alejandra Pérez, Luisa Martínez, Juan Bravo, Brenda Rodríguez, Paola Quintero , Pablo Moncada, Infection due to Aspergillus flavus and Rhizopus oryzae complex in a patient with diabetes mellitus , Biomedica: Vol. 43 No. 1 (2023)
- Angela María Londoño, Juan Raúl Castro-Ayarza, Amira Kronfly, Diana Camila Buitrago, Daniel Felipe Samacá, Epidemiology and healthcare resource utilization in atopic dermatitis in Colombia: A retrospective analysis of data from the National Health Registry from 2015 to 2020 , Biomedica: Vol. 43 No. 1 (2023)
Copyright (c) 2024 Biomedica
This work is licensed under a Creative Commons Attribution 4.0 International License.
Article metrics | |
---|---|
Abstract views | |
Galley vies | |
PDF Views | |
HTML views | |
Other views |